M Ventures (Merck Ventures B.V., MV)

https://www.merck-ventures.com

M Ventures is the strategic, corporate venture capital fund of science and technology company Merck. From its headquarters in the Netherlands and offices in Germany, USA and Israel, M Ventures invests globally in transformational ideas driven by innovative entrepreneurs. Taking an active role in its portfolio companies, M Ventures teams up with management teams and co-investors to translate scientific discoveries into commercial success. M Ventures focuses on identifying and financing novel solutions to some of the most difficult challenges, through company creation and equity investments in fields that will impact the vitality and sustainability of Merck's current and future businesses. *

	Start	2016-06-08 renamed
	Group	Merck (DE) (Group)
	Predecessor	MS Ventures (Merck Serono Ventures)
	Industry	venture capital
	Industry 2	BIOTECH
	Person	Liechtenstein, Therese Maria (Merck (DE) 202004 at M Ventures)
	Person 2	Autret, Arnaud (Illumina 202205– Head of European Operations at Illumina Ventures before M Ventures)

	Region	Amsterdam
	Country	Netherlands
	Street	84a Gustav Mahlerplein Ito Toren, 13th floor
	City	1082 MA Amsterdam
		Address record changed: 2024-01-05

Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	300,000,000 (capital, committed 2016-06-08)

		* Document for »About Section«: Enara Bio Ltd.. (10/3/24). "Press Release: Enara Bio Raises $32.5 Million Series B Financing to Advance First-in-Class Pipeline of TCR-based Immunotherapies Targeting Novel Dark Antigens". Oxford.

		Record changed: 2025-03-05